Company intelligence / Profile preview

Vencor Capital

Minneapolis, Minnesota, United Statesminktherapeutics.com ↗

Ownership: Private
Development stage: Other

Overview

Vensana Capital is a leading venture capital and growth equity investment firm founded in 2019. It partners with innovative medical technology companies across the development and commercial spectrum. The firm focuses on medtech—including medical devices, diagnostics, data science solutions, drug delivery technologies, digital health tools, life science tools—and tech-enabled healthcare services. Since inception it has invested in over 20 portfolio companies with six notable exits totaling nearly $3 billion.

Industry: Investors

Partnerships

Portfolio includes partnerships via investments/acquisitions such as ArtelonIntact VascularPersonal Genome DiagnosticsRelievant MedsystemsVesper Medical

Beyond the preview

Go deeper on Vencor Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vencor Capital.

Explore the full profile